Naringenin has been reported to have some promising pharmacological effects on the management of obesity and related metabolic complications including non-alcoholic fatty liver disease (NAFLD). Therefore, the present clinical trial study was done to assess the effects of naringenin supplementation on lipid profile, aminotransferase levels, severity of steatosis, as well as probability of fibrosis in overweight/obese patients with NAFLD.

中文翻译：

---

柚皮素补充剂能否改善超重/肥胖 NAFLD 患者的血脂状况、肝脂肪变性的严重程度和肝纤维化的可能性？一项随机、双盲、安慰剂对照的临床试验

据报道，柚皮素对肥胖症和相关代谢并发症（包括非酒精性脂肪性肝病 (NAFLD)）的管理具有一些有希望的药理作用。因此，本临床试验研究旨在评估柚皮素补充剂对超重/肥胖 NAFLD 患者的脂质分布、转氨酶水平、脂肪变性严重程度以及纤维化概率的影响。